ArticleTherapeutic advances in neurological disorders2016

Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.

Joleen T White et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.